Ignite Creation Date:
2025-12-24 @ 7:33 PM
Ignite Modification Date:
2026-01-13 @ 5:59 PM
Study NCT ID:
NCT00378703
Status:
COMPLETED
Last Update Posted:
2018-11-14
First Post:
2006-09-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
Sponsor:
National Cancer Institute (NCI)
Organization: